Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG3350 vs Tegaserod in Chronic Constipation
NCT00153140Phase 4Completed
- Sponsor
- Braintree Laboratories
- Start
- Jul 2004
- Primary completion
- Oct 2004
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol 3350 in chronic constipation (2 arms), sponsored by Braintree Laboratories. Primary endpoint: Successful outcome defined as no longer meeting the definition of constipation using ROME I criteria. Started Jul 2004; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00153140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153140.